Viewpoints: Subscription Pricing Could Expand HIV Drug Access; Make Nursing Home Inspections Unpredictable
Opinion writers delve into these public health topics.
Stat:
‘Netflix Pricing Model’ Could Make HIV Prevention Drug Far More Accessible
Figure 2 from the PURPOSE-1 trial changed the world. Between gray and red bars representing the study’s background HIV incidence and the arms randomized to receive oral pre-exposure prophylaxis (PrEP) was white space filled only by a previously unimaginable number: zero. Zero infections over one year among the 2,134 cisgender adolescent girls and young women who received the novel long-acting injectable antiretroviral lenacapavir. (Michael Rose, 4/3)
The Boston Globe:
Nursing Home Inspections Should Be Random
Facility owners may be slacking off right after the inspector departs. (Margaret Morganroth Gullette, 4/3)
Stat:
Why Would A Patient Trust A Peptide More Than A Statin?
A patient came to my office recently and told me she had stopped her statin. She’d been on it for two years. Her coronary artery calcium score was 280 and LDL was 168, up almost 100 points since she had stopped taking her statin. Her father had died from a heart attack at 58. (Vikas Patel, 4/3)
The Baltimore Sun:
Conversion Therapy Is Still Bad Medicine
This week's Supreme Court decision ignores how good medicine often comes down to what is said, not just done, by a health care professional. (Peter Jensen, 4/2)
Baltimore Business Journal:
This Physician-Led Model Is Challenging Private Equity's Grip On Health Care
The model combines private ownership with physician leadership, focusing on long-term growth rather than short-term profitability, writes a local health care executive. (Andrew Frankel, 4/3)
